PRESS RELEASE
News
-
-
PRESS RELEASE
Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
Sanofi's Tzield receives US FDA approval as first disease-modifying therapy for stage 3 type 1 diabetes, targeting autoimmune attack against insulin-producing beta cells -
-
-
PRESS RELEASE
Fox River Provides Reminder To Vote And Updated Dissent Rights
Fox River's special meeting for Securityholders to consider an Arrangement Resolution with Avenir Minerals Limited. Shareholders offered $1.10 per Common Share in cash. Voting instructions and reasons provided for the recommendation -
PRESS RELEASE
Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt Financing
Inventiva repays EIB loans, repurchases warrants, and issues new debt financing. Completes key steps in Combined Transaction. Details on Tranche A/B Convertible Bonds and Tranche B Amortized Bonds. Company focused on MASH treatment -
-
-
-
![Logo of [UNKNOWN]](https://logos.symex.be/img/.jpg)
